AMINOLEAN INJECTION DIN 00506990
Health Canada record
| Active ingredient(s) | ALANINE 0.8 MG; TYROSINE 0.2 MG; DEXTROSE 5 G; CALCIUM CHLORIDE 15 MG; POTASSIUM CHLORIDE 20 MG; MAGNESIUM SULFATE 20 MG; SODIUM ACETATE 250 MG; DEXPANTHENOL (CALCIUM D-PANTOTHENATE) 5 MG; THIAMINE HYDROCHLORIDE 10 MG; NICOTINAMIDE 150 MG; PYRIDOXINE HYDROCHLORIDE 10 MG; RIBOFLAVIN 5'-PHOSPHATE SODIUM 4 MG; VITAMIN B12 5 MCG; HISTIDINE 0.9 MG; DL-METHIONINE 0.3 MG; TRYPTOPHAN 0.3 MG; ISOLEUCINE 1.6 MG; ARGININE 1 MG; PHENYLALANINE 1 MG; VALINE 2 MG; LYSINE 2.5 MG; LEUCINE 2.5 MG; THREONINE 1.4 MG; L-ASPARTIC ACID 2 MG; SERINE 1.6 MG; GLUTAMIC ACID 6.7 MG; PROLINE 3.3 MG; GLYCINE 0.6 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intraperitoneal |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1980 |
| Current status date | 11-Jul-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bimeda-MTC Animal Health Inc. — licence 100306, currently licensed, last inspection rating NC (2026-03-02).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALANINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02498448 | CLINIMIX | BAXTER CORPORATION | Solution | ALANINE 1242 MG; L-ARGININE 690 MG; GLYCINE 618 MG; HISTIDINE 288 MG; L-ISOLEUCINE 360 MG; L-LEUCINE 438 MG; L-LYSINE HYDROCHLORIDE 348 MG; METHIONINE 240 MG; L-PHENYLALANINE 336 MG; L-PROLINE 408 MG; SERINE 300 MG; L-THREONINE 252 MG; TRYPTOPHAN 108 MG; L-TYROSINE 24 MG; L-VALINE 348 MG; DEXTROSE 5 G | Marketed |
| 02498456 | CLINIMIX | BAXTER CORPORATION | Solution | ALANINE 1656 MG; L-ARGININE 920 MG; GLYCINE 824 MG; HISTIDINE 384 MG; L-ISOLEUCINE 480 MG; L-LEUCINE 584 MG; L-LYSINE HYDROCHLORIDE 464 MG; METHIONINE 320 MG; L-PHENYLALANINE 448 MG; L-PROLINE 544 MG; SERINE 400 MG; L-THREONINE 336 MG; TRYPTOPHAN 144 MG; L-TYROSINE 32 MG; L-VALINE 464 MG; DEXTROSE 10 G | Marketed |
| 02498464 | CLINIMIX | BAXTER CORPORATION | Solution | ALANINE 1656 MG; L-ARGININE 920 MG; GLYCINE 824 MG; HISTIDINE 384 MG; L-ISOLEUCINE 480 MG; L-LEUCINE 584 MG; L-LYSINE HYDROCHLORIDE 464 MG; METHIONINE 320 MG; L-PHENYLALANINE 448 MG; L-PROLINE 544 MG; SERINE 400 MG; L-THREONINE 336 MG; TRYPTOPHAN 144 MG; L-TYROSINE 32 MG; L-VALINE 464 MG; DEXTROSE 14 G | Marketed |
| 02498413 | CLINIMIX E | BAXTER CORPORATION | Solution | ALANINE 1656 MG; L-ARGININE 920 MG; GLYCINE 824 MG; HISTIDINE 384 MG; L-ISOLEUCINE 480 MG; L-LEUCINE 584 MG; L-LYSINE HYDROCHLORIDE 464 MG; METHIONINE 320 MG; L-PHENYLALANINE 448 MG; L-PROLINE 544 MG; SERINE 400 MG; L-THREONINE 336 MG; TRYPTOPHAN 144 MG; L-TYROSINE 32 MG; L-VALINE 464 MG; DEXTROSE 10 G; SODIUM CHLORIDE 205 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; MAGNESIUM CHLORIDE 24 MG; CALCIUM CHLORIDE 33 MG | Marketed |
| 02498421 | CLINIMIX E | BAXTER CORPORATION | Solution | ALANINE 1656 MG; L-ARGININE 920 MG; GLYCINE 824 MG; HISTIDINE 384 MG; L-ISOLEUCINE 480 MG; L-LEUCINE 584 MG; L-LYSINE HYDROCHLORIDE 464 MG; METHIONINE 320 MG; L-PHENYLALANINE 448 MG; L-PROLINE 544 MG; SERINE 400 MG; L-THREONINE 336 MG; TRYPTOPHAN 144 MG; L-TYROSINE 32 MG; L-VALINE 464 MG; DEXTROSE 14 G; SODIUM CHLORIDE 205 MG; POTASSIUM PHOSPHATE DIBASIC 261 MG; MAGNESIUM CHLORIDE 24 MG; CALCIUM CHLORIDE 33 MG | Marketed |
| 02510324 | ESSEPNA | FRESENIUS KABI CANADA LTD | Solution | ALANINE 1.4 G; ARGININE 1.2 G; GLYCINE 1.1 G; HISTIDINE 0.3 G; ISOLEUCINE 0.5 G; LEUCINE 0.74 G; LYSINE (L-LYSINE ACETATE) 0.66 G; METHIONINE 0.43 G; PHENYLALANINE 0.51 G; PROLINE 1.12 G; SERINE 0.65 G; TAURINE 0.1 G; THREONINE 0.44 G; TRYPTOPHAN 0.2 G; TYROSINE 0.04 G; VALINE 0.62 G | Marketed |
International API supply for ALANINE
5 valid EDQM Certificates of Suitability from 5 holders. 10 active FDA Drug Master Files.
Request a quote for AMINOLEAN INJECTION